324 related articles for article (PubMed ID: 15902435)
1. Mice lacking the IFN-gamma receptor or fyn develop severe experimental autoimmune uveoretinitis characterized by different immune responses.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Udaka K; Ueno H
Immunogenetics; 2005 Jun; 57(5):337-43. PubMed ID: 15902435
[TBL] [Abstract][Full Text] [Related]
2. Regulation of experimental autoimmune uveoretinitis by anti-delta-like ligand 4 monoclonal antibody.
Ishida W; Fukuda K; Sakamoto S; Koyama N; Koyanagi A; Yagita H; Fukushima A
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):8224-30. PubMed ID: 21896864
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Th1 and Th2 cells in lymph nodes and spleens of mice during experimental autoimmune uveoretinitis.
Takeuchi M; Yokoi H; Tsukahara R; Sakai J; Usui M
Jpn J Ophthalmol; 2001; 45(5):463-9. PubMed ID: 11583666
[TBL] [Abstract][Full Text] [Related]
4. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
5. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
6. Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
Kwak HJ; Yang YS; Pae HO; Kim YM; Chung HT
Mol Cells; 2001 Oct; 12(2):178-84. PubMed ID: 11710518
[TBL] [Abstract][Full Text] [Related]
7. Delayed onset and decreased severity of experimental autoimmune uveoretinitis in mice lacking nitric oxide synthase type 2.
Thillaye-Goldenberg B; Goureau O; Naud MC; de Kozak Y
J Neuroimmunol; 2000 Oct; 110(1-2):31-44. PubMed ID: 11024532
[TBL] [Abstract][Full Text] [Related]
8. Intraocular cytokine quantification of experimental autoimmune uveoretinitis in rats.
Okada AA; Sakai J; Usui M; Mizuguchi J
Ocul Immunol Inflamm; 1998 Jun; 6(2):111-20. PubMed ID: 9689641
[TBL] [Abstract][Full Text] [Related]
9. [Expression of suppressor of cytokine signaling in retina of experimental autoimmune uveoretinitis].
Wang H; Zhou ZC; Peng XY; Zhao M
Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):876-82. PubMed ID: 19176113
[TBL] [Abstract][Full Text] [Related]
10. SLAT/Def6 plays a critical role in the pathogenic process of experimental autoimmune uveitis (EAU).
Vistica BP; Shi G; Nugent L; Tan C; Altman A; Gery I
Mol Vis; 2012; 18():1858-64. PubMed ID: 22815639
[TBL] [Abstract][Full Text] [Related]
11. Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis.
Tarrant TK; Silver PB; Chan CC; Wiggert B; Caspi RR
J Immunol; 1998 Jul; 161(1):122-7. PubMed ID: 9647215
[TBL] [Abstract][Full Text] [Related]
12. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
13. Differential roles for IFN-gamma and IL-17 in experimental autoimmune uveoretinitis.
Yoshimura T; Sonoda KH; Miyazaki Y; Iwakura Y; Ishibashi T; Yoshimura A; Yoshida H
Int Immunol; 2008 Feb; 20(2):209-14. PubMed ID: 18156624
[TBL] [Abstract][Full Text] [Related]
14. Invariant natural killer T cells play dual roles in the development of experimental autoimmune uveoretinitis.
Satoh M; Namba KI; Kitaichi N; Endo N; Kitamei H; Iwata D; Ohno S; Ishida S; Onoé K; Watarai H; Taniguchi M; Ishibashi T; Stein-Streilein J; Sonoda KH; Van Kaer L; Iwabuchi K
Exp Eye Res; 2016 Dec; 153():79-89. PubMed ID: 27720708
[TBL] [Abstract][Full Text] [Related]
15. Regulatory effects of IFN-β on the development of experimental autoimmune uveoretinitis in B10RIII mice.
Sun M; Yang Y; Yang P; Lei B; Du L; Kijlstra A
PLoS One; 2011 May; 6(5):e19870. PubMed ID: 21573074
[TBL] [Abstract][Full Text] [Related]
16. Leucine-Rich Repeat Kinase 2 (Lrrk2) Deficiency Diminishes the Development of Experimental Autoimmune Uveitis (EAU) and the Adaptive Immune Response.
Wandu WS; Tan C; Ogbeifun O; Vistica BP; Shi G; Hinshaw SJ; Xie C; Chen X; Klinman DM; Cai H; Gery I
PLoS One; 2015; 10(6):e0128906. PubMed ID: 26067490
[TBL] [Abstract][Full Text] [Related]
17. Kinetics of intraocular cytokines in the suppression of experimental autoimmune uveoretinitis by type I IFN.
Okada AA; Keino H; Suzuki J; Sakai J; Usui M; Mizuguchi J
Int Immunol; 1998 Dec; 10(12):1917-22. PubMed ID: 9885913
[TBL] [Abstract][Full Text] [Related]
18. Behavioral Conditioning of Immune Responses with Cyclosporine A in a Murine Model of Experimental Autoimmune Uveitis.
Bauer D; Busch M; Pacheco-López G; Kasper M; Wildschütz L; Walscheid K; Bähler H; Schröder M; Thanos S; Schedlowski M; Heiligenhaus A
Neuroimmunomodulation; 2017; 24(2):87-99. PubMed ID: 28848192
[TBL] [Abstract][Full Text] [Related]
19. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
20. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
